Q1 2019 13F Holders as of 3/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.9M
-
Number of holders
-
202
-
Total 13F shares, excl. options
-
41.3M
-
Shares change
-
+976K
-
Total reported value, excl. options
-
$1.57B
-
Value change
-
+$30M
-
Put/Call ratio
-
0.58
-
Number of buys
-
107
-
Number of sells
-
-92
-
Price
-
$38.06
Significant Holders of Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) as of Q1 2019
250 filings reported holding PCRX - Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share as of Q1 2019.
Pacira BioSciences, Inc. - Common Stock, par value $0.001 per share (PCRX) has 202 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 41.3M shares
of 44.9M outstanding shares and own 92.06% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3.92M shares), Consonance Capital Management LP (3.65M shares), BlackRock Inc. (3.32M shares), MACQUARIE GROUP LTD (1.81M shares), FRONTIER CAPITAL MANAGEMENT CO LLC (1.38M shares), Rock Springs Capital Management LP (1.25M shares), Stephens Investment Management Group LLC (1.2M shares), Clearbridge Investments, LLC (1.15M shares), MILLENNIUM MANAGEMENT LLC (1.09M shares), and ARMISTICE CAPITAL, LLC (1.07M shares).
This table shows the top 202 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.